ArticleBioengineering (Basel, Switzerland)2026
Development of an Integrated Radiotherapy Simulation Platform with AI-Driven Segmentation and Ray-Casting-Based Dosimetric Evaluation.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Radiotherapy simulation is essential for accurately targeting tumors while preserving healthy tissue, ensuring treatment precision and safety. This study aimed to develop an integrated radiotherapy simulation system capable of automated segmentation, dose estimation, and collision detection within a virtual planning environment to enhance efficiency and reduce costs in radiotherapy treatment planning. The Point Transformer model was applied to organ point cloud data derived from CT medical imaging for automated segmentation. Farthest point sampling (FPS) was employed to downsample the data before training. To enhance the accuracy and anatomical fidelity of the AI-generated segmentation results, reconstruction and refinement algorithms, including k-d tree, outlier removal, marching cubes, and surface smoothing, were implemented. Beam penetration simulation with the ray casting algorithm was employed for correction-based dose estimation. A collision detection module was incorporated to identify potential machine-machine or machine-patient interactions. The entire workflow was executed within a Unity 3D-based virtual simulation environment. As a result, the Point Transformer model demonstrated high segmentation accuracy, achieving Dice scores of 93.86 ± 1.50% for single-organ and 91.86 ± 3.25% for multi-organ cases, surpassing the performance of PointNet++. Applying ray casting for the refined surface meshes generated through post-processing enabled accurate dose estimation with discrepancies of 3.5% (brain), 5.9% (liver), and 13.8% (lung) compared to a Pinnacle TPS. The proposed method provides a low-cost and adaptable solution that enables easy modification and further development, making it particularly suitable for widespread applications in radiotherapy research, education, and clinical workflow optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.